Latest News
TTUHSC Researchers Receive New NIH Grant to Continue Studying Amygdala-Pain Link
The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.
TTUHSC Scientist Seeking Solution to Antibiotic Resistance
A team of researchers led by Hongjun (Henry) Liang, Ph.D., from the Texas Tech University Health Sciences Center (TTUHSC) Department of Cell Physiology and Molecular Biophysics, recently investigated whether or not a series of novel nanoparticles can kill some of the pathogens that lead to human infection without affecting healthy cells.
TTUHSC Researchers Receive Patent for Identifying Viable Embryos
The Texas Tech Office of Research Commercialization (ORC) filed an initial U.S. patent application in 2016, and a patent was awarded to Prien and Penrose on Nov. 8, 2021.
TTUHSC Researcher Investigates Ways to Enhance Neurolysin Activity in the Brain
Vardan Karamyan, Ph.D., in a recent collaborative study, continues his previous work evaluating the potential of Nln as a therapeutic target for stroke by seeking to identify small molecules capable of enhancing the activity and catalytic efficiency of Nln.
TTUHSC Technology Leads Successful Clinical Trial to Treat Dry Eye Disease
Hironmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Study Could Lead to New Treatments for Neuroblastoma
In previous research, a team of investigators led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, began studying the potential for using the ways cancer cells maintain telomeres — the protective caps on the end of chromosomes — to attack certain cancer cells.
Study of CVD Risk Factors on Cognitive Dysfunction in Elderly Rural West Texans Presented in Journal of Alzheimer’s Disease Reports
A team of researchers led by P. Hemachandra Reddy, Ph.D., professor of internal medicine, neurology and neuroscience at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine and Hafiz Khan, Ph.D., professor for the Julia Jones Matthews Department of Public Health at the TTUHSC Graduate School of Biomedical Sciences, completed a study to better understand the risk factors for cardiovascular disease (CVD), dementia and Alzheimer’s disease in a rural population.
TTUHSC Study: Pandemic, Restrictions Have Increased Mental Health Risks for Nursing Home Caregivers
Ashish Sarangi, M.D., recently conducted research into the mental health consequences of COVID-19 geriatric care in a nursing home setting. His research, “A Descriptive Study Evaluating the Impact of COVID-19 on Delivery of Care and Mental Health of Geriatric Nursing Home Staff,” was published in the April issue of the American Journal of Geriatric Psychiatry.
Journal Publishes Research Review by TTUHSC Pharmacy Investigator
In a focused review to Physiological Reports, Vardan Karamyan, Ph.D., addresses three peptides that could be causing severe COVID-19 complications
Faculty Honored at State of the University & Faculty Award Convocation
During a virtual presentation of the 2021 TTUHSC State of the University & Faculty Award Convocation, faculty members and teams were recognized for excellence in teaching, research, teamwork and more.
TTUHSC’s Phy Seeks Answers for Women With Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in reproductive- aged women. It affects at least 10% of women, increasing their risk of obesity, diabetes, heart disease, cancer and infertility. To help improve the health of these women, a research team led by Jennifer Phy, D.O., an associate professor at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, developed a new dietary approach to managing the syndrome.
Study Shows a Healthy Heart Can Reduce Ocular Disease
At the Texas Tech University Health Sciences Center (TTUHSC), a research team led by Duke Appiah, Ph.D., an assistant professor and director of the university’s master of public health program, recently completed a study to better understand how LS7 may influence ocular health.
Novel Treatment Offers Relief to Peripheral Artery Disease Patients
PAD is a potentially life-threatening condition caused by the buildup of plaque that narrows and restricts blood flow to the body’s peripheral arteries. Texas Tech Physicians are the first in Texas to take on this new procedure.
Study Suggests Increased Risks for COVID-19 Patients Who Smoke, Vape
Luca Cucullo, Ph.D., and TTUHSC graduate research assistant Sabrina Rahman Archie reviewed the role smoking and vaping may play in the cerebrovascular and neurological dysfunction of those who contract the virus.
TTUHSC Researchers Developing Anti-Viral Drug for COVID-19
Scientists in laboratories across the country and throughout the world are investigating myriad drugs, therapies and vaccines to thwart the COVID-19 spread. One of those scientists is Ted Reid, Ph.D., a professor in the Texas Tech University Health Sciences Center (TTUHSC) Department of Ophthalmology and Visual Sciences who specializes in selenium research.
Study Could Lead to New Scale for Stratifying Neuroblastoma Risk
Results from a study conducted by a research team led by C. Patrick Reynolds, M.D., Ph.D., director of the TTUHSC School of Medicine Cancer Center, may prove to be a landmark in pediatric oncology.
Texas Tech University Health Sciences Center Teams Bring Convalescent Plasma Treatments to West Texas
TTUHSC medical teams from the Panhandle and South Plains recently joined a study led by the Mayo Clinic to use convalescent plasma in severely-ill patients with coronavirus (COVID-19).
TTUHSC Team Decontaminates PPE to Solve Shortages
One suggested way to reduce the stress COVID-19 has placed on the PPE supply chain is to extend the lifetime of existing equipment. With that in mind, a team from TTUHSC has been studying a method that can decontaminate used PPE, especially N95 masks and face shields.
Young Scientists Meet in Lubbock for 2020 Student Research Week
Students from the TTUHSC Graduate School of Biomedical Sciences and the Department of Cell Biology and Biochemistry hosted the university’s 32nd Student Research Week March 10-13 in Lubbock.
Published Consensus Statement Offers UTI Treatment Recommendations
As a member of AMDA’s Infection Advisory Committee, Kalin Clifford, Pharm.D., an assistant professor for the TTUHSC Jerry H. Hodge School of Pharmacy, helped develop a consensus statement in an effort to devise consistent guidelines for treating urinary tract infections.
Tags
- #Abilene
- #Administration
- #Alumni
- #Amarillo
- #Breast Center of Excellence
- #Campus Life
- #COVID-19
- #Dallas
- #Development
- #Diversity
- #Education
- #Emergency
- #Events
- #F. Marie Hall Institute for Rural and Community Health
- #F. Marie Hall SimLife Center
- #Faculty
- #Feature Stories
- #Garrison Institute on Aging
- #General
- #Graduate School of Biomedical Sciences
- #Health
- #Hispanic-Serving Institution
- #Laura W. Bush Institute for Women's Health
- #Lubbock
- #Managed Care
- #Mental Health Initiative
- #Mental Health Resource Hub
- #Military
- #Miscellaneous
- #News Releases
- #Paul L. Foster School of Medicine
- #Permian Basin
- #President
- #Public Art
- #Research
- #School of Health Professions
- #School of Medicine
- #School of Nursing
- #School of Pharmacy
- #School of Population and Public Health
- #Staff
- #Statline
- #Stories
- #Students
- #Team Member Spotlight
- #Texas Tech Physicians
- #The Free Clinic
- #TTUHSC in the News
- #Values
- #Videos
- #Vision
- #Well Beyond
- #Women's Health